DE111668C - - Google Patents
Info
- Publication number
- DE111668C DE111668C DENDAT111668D DE111668DA DE111668C DE 111668 C DE111668 C DE 111668C DE NDAT111668 D DENDAT111668 D DE NDAT111668D DE 111668D A DE111668D A DE 111668DA DE 111668 C DE111668 C DE 111668C
- Authority
- DE
- Germany
- Prior art keywords
- uric acid
- acid
- methyl
- parts
- mol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 12
- 229940116269 uric acid Drugs 0.000 claims description 12
- DCZFGQYXRKMVFG-UHFFFAOYSA-N cyclohexane-1,4-dione Chemical compound O=C1CCC(=O)CC1 DCZFGQYXRKMVFG-UHFFFAOYSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000004970 halomethyl group Chemical group 0.000 claims 1
- -1 uric acid alkali salt Chemical class 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- QFDRTQONISXGJA-UHFFFAOYSA-N 1-methyluric acid Chemical compound O=C1N(C)C(=O)NC2=C1NC(=O)N2 QFDRTQONISXGJA-UHFFFAOYSA-N 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000005804 alkylation reaction Methods 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- ZQINVZROMLALDU-UHFFFAOYSA-N 8-chloro-3-methyl-7h-purine-2,6-dione Chemical compound O=C1NC(=O)N(C)C2=C1NC(Cl)=N2 ZQINVZROMLALDU-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000007968 uric acids Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/14—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with two methyl radicals in positions 1 and 3 and two methyl radicals in positions 7, 8, or 9
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE93112T |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE111668C true DE111668C (cg-RX-API-DMAC7.html) |
Family
ID=33035591
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT91811D Active DE91811C (cg-RX-API-DMAC7.html) | |||
| DENDAT93112D Active DE93112C (cg-RX-API-DMAC7.html) | |||
| DENDAT111668D Active DE111668C (cg-RX-API-DMAC7.html) | |||
| DENDAT94631D Active DE94631C (cg-RX-API-DMAC7.html) | |||
| DENDAT92310D Active DE92310C (cg-RX-API-DMAC7.html) |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT91811D Active DE91811C (cg-RX-API-DMAC7.html) | |||
| DENDAT93112D Active DE93112C (cg-RX-API-DMAC7.html) |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT94631D Active DE94631C (cg-RX-API-DMAC7.html) | |||
| DENDAT92310D Active DE92310C (cg-RX-API-DMAC7.html) |
Country Status (1)
| Country | Link |
|---|---|
| DE (5) | DE92310C (cg-RX-API-DMAC7.html) |
-
0
- DE DENDAT91811D patent/DE91811C/de active Active
- DE DENDAT93112D patent/DE93112C/de active Active
- DE DENDAT111668D patent/DE111668C/de active Active
- DE DENDAT94631D patent/DE94631C/de active Active
- DE DENDAT92310D patent/DE92310C/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE92310C (cg-RX-API-DMAC7.html) | |
| DE91811C (cg-RX-API-DMAC7.html) | |
| DE94631C (cg-RX-API-DMAC7.html) | |
| DE93112C (cg-RX-API-DMAC7.html) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE111668C (cg-RX-API-DMAC7.html) | ||
| DE271820C (cg-RX-API-DMAC7.html) | ||
| CH149007A (de) | Verfahren zur Darstellung eines halogenhaltigen basischen Äthers. | |
| DE301499C (cg-RX-API-DMAC7.html) | ||
| DE637385C (de) | Verfahren zur Herstellung von 2, 4-Dioxo-1, 3, 3-trialkyl- und -1, 3, 3, 6-tetraalkyltetrahydropyridinen | |
| DE221385C (cg-RX-API-DMAC7.html) | ||
| DE153861C (cg-RX-API-DMAC7.html) | ||
| DE125988C (cg-RX-API-DMAC7.html) | ||
| DE495103C (de) | Verfahren zur Darstellung von Verbindungen der ª†-Aminoglykomonoaether und ihrer Abkoemmlinge | |
| DE561281C (de) | Verfahren zur Darstellung von Diaryldioxyessigsaeuren | |
| DE686908C (de) | Verfahren zur Darstellung von 5-Oxytrimellitsaeure | |
| DE876093C (de) | Verfahren zur Herstellung von Phosphorderivaten von Thiosemicarbazonen | |
| DE554700C (de) | Verfahren zur Darstellung von Estersaeuren | |
| DE511211C (de) | Verfahren zur Darstellung von o-Cyanaryirhodanverbindungen | |
| DE500162C (de) | Verfahren zur Darstellung von 4-Methyl-6-halogen-3-oxy-1-thionaphthenen | |
| DE169358C (cg-RX-API-DMAC7.html) | ||
| DE50835C (de) | Verfahren zur Darstellung der Carbonsäuren des Metaamidophenols und seiner Alkylderivate | |
| DE185800C (cg-RX-API-DMAC7.html) | ||
| AT61189B (de) | Verfahren zur Darstellung von Zyanamidoameisensäureestern. | |
| DE199175C (cg-RX-API-DMAC7.html) | ||
| DE708430C (de) | Verfahren zur Darstellung von Polycarbonsaeureestern der Genine herzwirksamer Glykoside | |
| DE512820C (de) | Verfahren zur Herstellung von Oxyanthrachinonderivaten, insbesondere Alizarin und seinen Derivaten | |
| DE193114C (cg-RX-API-DMAC7.html) | ||
| AT145823B (de) | Verfahren zur Darstellung wasserlöslicher Pyridinderivate. | |
| DE389359C (de) | Verfahren zur Darstellung von d-4-und 1-4-Cocain |